Quarter Financials
Avidity Biosciences, Inc. (RNA)
$5.89
-0.49 (-7.68%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -47 | -47 | -48 | -42 | -44 | -34 | -39 | -29 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -458 | -411 | -359 | -308 | -264 | -219 | -185 | -146 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | -1 | -2 | -1 | 0 | -1 | -1 | -2 | -1 |
|---|
| Net PPE | 16 | 16 | 15 | 15 | 16 | 15 | 16 | 3 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | - | -85 | -175 | -38 | -54 | -90 | -251 | -24 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|